Position in BDSX
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$969
+$147 QoQ
Shares Held
43
+95.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#43
of 44 holders
Holding Since
Dec 2020
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BDSX Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026JPMORGAN CHASE & CO holds $14,872,166,546 across 37 Diagnostics & Research names. BDSX ranks #33 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
8,503,527 | $4,263,328,287 | |
| 2 | NTRA |
Natera, Inc.
|
12,865,346 | $3,492,298,164 | |
| 3 | DHR |
Danaher Corp /De/
|
12,185,400 | $2,321,074,982 | |
| 4 | IQV |
Iqvia Holdings Inc.
|
6,139,775 | $1,186,327,314 | |
| 5 | WAT |
Waters Corp /De/
|
2,158,391 | $809,482,952 | |
| 6 | DGX |
Quest Diagnostics Inc
|
3,520,438 | $746,156,824 | |
| 7 | IDXX |
Idexx Laboratories Inc /De
|
755,791 | $397,878,607 | |
| 8 | LH |
Labcorp Holdings Inc.
|
1,268,384 | $355,147,520 |
All Filings in BDSX
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $969 | 43 | Shares | Defined | 2026-08-12 | |
| 2023-12-31 | $822 | 447 | Shares | Defined | 2024-12-26 | |
| 2023-09-30 | $18 | 11 | Shares | Defined | 2023-11-14 | |
| 2022-03-31 | $30,899 | 18,284 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $260,505 | 49,245 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $378,596 | 46,058 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $141,716 | 10,728 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $167,617 | 8,253 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $161,742 | 8,023 | Shares | Defined | 2021-02-19 | |
| No filing history on record for this holder in this stock. | ||||||